[The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
作者信息
Dehtiar'ova I I, Chernenko V V, Anokhina H A, Opanasiuk N D, Pavlik-Novol's'kyĭ T, Haĭsenko A V
出版信息
Lik Sprava. 1995 Sep-Dec(9-12):47-8.
PMID:8983789
Abstract
摘要
相似文献
1
[The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].[熊去氧胆酸在肝胆系统慢性疾病中的应用特点]
Lik Sprava. 1995 Sep-Dec(9-12):47-8.
2
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.熊去氧胆酸和胆汁酸衍生物用于肝胆疾病的治疗方法。
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S1. doi: 10.1016/S2210-7401(12)70014-1.
3
[New aspects of pharmacological effects of ursodeoxycholic acid].熊去氧胆酸药理作用的新进展
Eksp Klin Gastroenterol. 2014(8):4-10.
4
[Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].[克罗恩病中的肝胆病变及保守治疗方法]
Eksp Klin Gastroenterol. 2013(6):3-6.
5
[Odeston in treatment of chronic diseases of hepatobiliary system].[奥地斯顿在肝胆系统慢性疾病治疗中的应用]
Voen Med Zh. 2001 Feb;322(2):49-53.
6
Ursodeoxycholic acid in the treatment of liver diseases.熊去氧胆酸在肝脏疾病治疗中的应用。
Postgrad Med J. 1997 Feb;73(856):75-80. doi: 10.1136/pgmj.73.856.75.
7
Ursodeoxycholic acid therapy in hepatobiliary disease.熊去氧胆酸在肝胆疾病中的治疗作用
Am J Med. 2000 Apr 15;108(6):481-6. doi: 10.1016/s0002-9343(00)00318-1.
8
Use of ursodeoxycholic acid in liver diseases.熊去氧胆酸在肝脏疾病中的应用。
J Gastroenterol Hepatol. 2001 Jan;16(1):3-14. doi: 10.1046/j.1440-1746.2001.02376.x.
9
[Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
Clin Ter. 1978 Sep 15;86(5):485-94.
10
Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease.细胞保护剂在犬猫肝胆疾病中的治疗应用。
Vet Clin North Am Small Anim Pract. 2009 May;39(3):631-52. doi: 10.1016/j.cvsm.2009.02.002.
Zotero 插件